DNA RNA and Cells

15 May 2017 Tactiva Therapeutics Presents Positive Data on Novel Dual CD4/CD8 T Cell Receptor in Preclinical Models of Cancer
15 May 2017 Advaxis Provides Phase 1 Data of Higher Dose Axalimogene Filolisbac
15 May 2017 Sangamo Therapeutics Presents Recent Developments from Research and Clinical Programs at Annual Meeting of the American Society of Gene & Cell Therapy
15 May 2017 MOLOGEN AG: Recruitment goal achieved for the pivotal IMPALA study with lefitolimod in colorectal cancer patients
15 May 2017 Isarna Presents Positive Clinical Data for ISTH0036 in Advanced Glaucoma and Preclinical Data Supportive of AMD/DME Potential at ARVO 2017 Annual Conference
15 May 2017 Ionis Pharmaceuticals Announces Phase 3 NEURO-TTR Study of Inotersen (IONIS-TTR Rx) Meets Both Primary Endpoints
14 May 2017 Editas Medicine Demonstrates First Achievement of In Vivo Editing in Non-human Primate Retinas
14 May 2017 Intellia Therapeutics Announces Progress with CRISPR/Cas9 at the American Society of Gene & Cell Therapy Annual Meeting
13 May 2017 Capricor Therapeutics Provides Update on ALLSTAR Trial
13 May 2017 First study of Oncolytic HSV-1 in children and young adults with cancer indicates safety, tolerability
11 May 2017 VBL Therapeutics Presents Data on VB-111 in Combination with Checkpoint Inhibitor at the 20th Annual ASGCT Meeting
11 May 2017 AGTC Presents New Data on its AAV-Based Gene Therapies for the Treatment of Achromatopsia and X-Linked Retinitis Pigmentosa at the American Society of Gene and Cell Therapy 20th Annual Meeting
11 May 2017 Editas Medicine Announces Pre-Clinical Data for Program to Treat Sickle Cell Disease and Beta-Thalassemia
11 May 2017 DNAtrix Oncolytic Myxoma Virus Eliminates Treatment-Resistant Cancer
11 May 2017 Dimension Therapeutics Reports First Quarter 2017 Financial Results and Provides Corporate Update
10 May 2017 uniQure Presents New Data Demonstrating Successful and Effective Transduction of AAV5 Vector in the Presence of Pre-Existing Neutralizing Antibodies in Non-Human Primates
10 May 2017 OncoSec Announces Clinical Collaboration with Merck to Evaluate Combination of ImmunoPulse® IL-12 and KEYTRUDA® (pembrolizumab) for Metastatic Melanoma
10 May 2017 Agilis Biotherapeutics Announces Presentation of Data from Phase I/II Trial for Treatment of AADC Deficiency
10 May 2017 Vericel Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Ixmyelocel-T for the Treatment of Advanced Heart Failure Due to Ischemic Dilated Cardiomyopathy
10 May 2017 Adaptimmune Announces Initiation of Study to Evaluate SPEAR T-Cell Therapy Targeting AFP in Liver Cancer
10 May 2017 Targovax recruits first patient into first ONCOS-102 /Checkpoint inhibitor melanoma study
10 May 2017 First-In-Human Clinical Trial Aims to Extend Remission for Children and Young Adults With Leukemia Treated With T-Cell Immunotherapy
09 May 2017 Eyevensys Announces the First-in-Human Treatment with its GroundBreaking EyeCET ElectroTransfection Technology for Eye Diseases
03 May 2017 Pluristem Announces Promising Results from Non-Human Primate Pilot Study of PLX-R18 in Acute Radiation Syndrome
03 May 2017 Rigontec Starts First-In-Human, Phase I/II Trial of RIG-I Agonist RGT100 and Appoints Eugen Leo as Chief Medical Officer

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top